APA (7th ed.) Citation

Dai, G., Dai, G., Tang, F., Tang, F., Wang, P., Wang, P., . . . Wang, D. Pembrolizumab combined with lenvatinib and metronomic cyclophosphamide in platinum-resistant ovarian cancer: A case report of durable clinical response. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Dai, Guanlin, Guanlin Dai, Furong Tang, Furong Tang, Ping Wang, Ping Wang, Danqing Wang, and Danqing Wang. Pembrolizumab Combined with Lenvatinib and Metronomic Cyclophosphamide in Platinum-resistant Ovarian Cancer: A Case Report of Durable Clinical Response. Frontiers Media S.A.

MLA (9th ed.) Citation

Dai, Guanlin, et al. Pembrolizumab Combined with Lenvatinib and Metronomic Cyclophosphamide in Platinum-resistant Ovarian Cancer: A Case Report of Durable Clinical Response. Frontiers Media S.A.